Seminars in Oncology
Volume 36, Issue 2 , Pages 84-89 , April 2009

Breast Cancer With Positive Sentinel Lymph Node: Now What?

References 

  1. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10:1140–1151
  2. Cox C, Kiluk J, Riker A, Cox J, Allred N, Ramos D, et al. Significance of sentinel lymph node micrometastasis in human breast cancer. J Am Coll Surg. 2008;206:261–268
  3. Truong PT, Vinh-Hung V, Cserni G, Woodward WA, Tai P, Vlastos G, et al. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer. 2008;44:1670–1677
  4. Karlsson P, Cole BF, Price KN, Coates AS, Castiglione-Gertsch , Gusterson BA, et al. The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol. 2007;25:2019–2026
  5. Regan MM, Pagani O, Walley B, Torrisi R, Perez EA, Francis P, et al. Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?. Ann Oncol. 2008;19:1231–1241
  6. Nagashima T, Sakakibara M, Nakano S, Tanabe N, Nakamura R, Nakatani Y, et al. Sentinel node micrometastasis and distant failure in breast cancer patients. Breast Cancer. 2006;13:186–191
  7. Spencer B, Kim E, Easley S, Wang N, Shenk R, Leeming R, et al. Incidence of axillary nodal positivity in patients presenting with isolated tumor cell clusters or micrometastases in sentinel lymph nodes. [abstract 2001]. Proceedings of the San Antonio Breast Cancer Symposium 2006;San Antonio, TX
  8. Hansen NM, Grube BL, Ye C, Turner R, Brennan M, Brenner J, et al. The impact of micrometastases in the sentinel nodes of patients with invasive breast cancer [abstract 52]. Proceedings of the San Antonio Breast Cancer Symposium 2007;San Antonio, TX
  9. Rutgers EJ. Micrometastases in the sentinel node: take it or leave it? [abstract P-3]. Proceedings of the San Antonio Breast Cancer Symposium 2006;San Antonio, TX
  10. Alran S, De Rycke Y, Fourchotte V, Chritansky H, Salmon RJ. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy [abstract 2002]. Proceedings of the San Antonio Breast Cancer Symposium 2006;San Antonio, TX
  11. de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, Adang EM, et al. Micrometastases and isolated tumor cells: relevant and robust or rubbish?. (MIRROR): preliminary results of the MIRROR study from the Dutch Breast Cancer Trialists' Group (BOOG) [abstract 23]. Proceedings of the San Antonio Breast Cancer Symposium 2008;San Antonio, TX
  12. Albain K, Barlow W, Shak S, Hortobagyi G, Livingston R, Yeh I, et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal, node-positive, ER-positive breast cancer (S8814, INT0100) [abstract 10]. Proceedings of the San Antonio Breast Cancer Symposium 2007;San Antonio, TX
  13. Bolster MJ, Peer PGM, Bult P, Thunnisen FBJM. Risk factors for non-sentinel lymph node metastases in patients with breast cancer (The outcome of a multi-institutional study). Ann Surg Oncol. 2007;14:181–189

PII: S0093-7754(09)00002-5

doi: 10.1053/j.seminoncol.2009.01.001

Seminars in Oncology
Volume 36, Issue 2 , Pages 84-89 , April 2009

Article Tools

* Image Usage & Resolution